TCG Crossover GP II, LLC - 27 Oct 2025 SCHEDULE 13G Report for ADC Therapeutics SA Common Shares, par value CHF $0.08 per share (ADCT)

Filing Manager
TCG Crossover GP II, LLC
Reporting Manager
TCG Crossover GP II, LLC
Security
ADC Therapeutics SA Common Shares, par value CHF $0.08 per share
Symbol
ADCT
Shares outstanding
123,806,250 shares
Disclosed Ownership
11,390,175 shares
Ownership
9.2%
Form type
SCHEDULE 13G
Filing time
17 Feb 2026, 16:26:45 UTC
Date of event
27 Oct 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
TCG Crossover GP II, LLC 9.2% 11,390,175 0 11,390,175 /s/ Craig Skaling Craig Skaling, Authorized Signatory
TCG Crossover Fund II, L.P. 9.2% 11,390,175 0 11,390,175 /s/ Craig Skaling Craig Skaling, Authorized Signatory
Chen Yu 9.2% 11,390,175 0 11,390,175 /s/ Craig Skaling Craig Skaling, as Attorney-in-Fact for Chen Yu